92686-04-9

Basic information

• Product Name: <3R-<3α(R^*),4β>>-1-(2,4-dimethoxybenzyl)-3-(1-hydroxyethyl)-4-acetoxy-2-azetidinone
• CAS NO: 92686-04-9
• Molecular Weight: 323.346
• Mol File: 92686-04-9.mol

Chemical Properties

• CAS DataBase Reference: <3R-<3α(R^*),4β>>-1-(2,4-dimethoxybenzyl)-3-(1-hydroxyethyl)-4-acetoxy-2-azetidinone(CAS DataBase Reference)
• NIST Chemistry Reference: <3R-<3α(R^*),4β>>-1-(2,4-dimethoxybenzyl)-3-(1-hydroxyethyl)-4-acetoxy-2-azetidinone(92686-04-9)
• EPA Substance Registry System: <3R-<3α(R^*),4β>>-1-(2,4-dimethoxybenzyl)-3-(1-hydroxyethyl)-4-acetoxy-2-azetidinone(92686-04-9)

Safety Data

• Hazardous Substances Data: 92686-04-9(Hazardous Substances Data)

Upstream product

• 81902-68-3 (2S,3R)-N-(2,4-dimethoxybenzyl)-N-(t-butoxycarbonylmethyl)-2,3-epoxybutyramide 
• 81902-60-5 t-butyl N-(2,4-dimethoxybenzyl)glycinate 
• 81902-59-2 (2S,3R)-N-(2,4-dimethoxybenzyl)-N-(t-butoxycarbonylmethyl)-2-bromo-3-hydroxybutyramide 
• 80829-72-7 <3S-<3α(S^*),4β>>-t-butyl 1-(2,4-dimethoxybenzyl)-3-(1-hydroxyethyl)-2-azetidinone-4-carboxylate 
• 20781-21-9 2,4-dimethoxybenzylamine hydrochloride 

Downstream Products

• 92685-98-8 <3S-<3α(S^*),4β>>-1-(2,4-dimethoxybenzyl)-3-(1-t-butyldimethylsilyloxyethyl)-4-(2-oxo-3-chloropropyl)-2-azetidinone 
• 92685-92-2 <3S-<3α(S^*),4β>>-<1-(2,4-dimethoxybenzyl)-3-(1-t-butyldimethylsilyloxyethyl)-2-azetidinone-4-yl>acetic acid 
• 92685-97-7 [(2R,3S)-3-[(R)-1-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-1-(2,4-dimethoxy-benzyl)-4-oxo-azetidin-2-yl]-acetyl chloride 
• 81902-65-0 <3S-<3α(S^*),4β>>-benzyl<1-(2,4-dimethoxybenzyl)-3-(1-t-butyldimethylsilyloxyethyl)-2-azetidinone-4-yl>acetate 
• 87392-18-5 <3S-<3α(S^*),4β>>-benzyl<3-(1-t-butyldimethylsilyloxyethyl)-2-azetidinone-4-yl>acetate 
• 92685-93-3 <3R-<3α(R^*),4β>>-1-(2,4-dimethoxybenzyl)-3-(1-t-butyldimethylsilyloxyethyl)-4-acetoxy-2-azetidinone 

Relevant articles and documents

STEREOSPECIFIC SYNTHESIS OF CHIRAL PRECURSORS OF THIENAMYCIN FROM L-THREONINE

L-Threonine was transformed, stereospecifically, to a versatile β-lactam (5a) in 3 steps.This β-lactam was further converted to a key intermediate (25) for the synthesis of thienamycin and its biologically active analogues.Furthermore, the compound 5a was changed to iodides (18 and 23), cyanides (19 and 24), chloromethylketone (26) and aldehydes (30 and 31) which appear to have a latent potential as precursors for the syntheses of the carbapenems.